References
Dec 1, 1992·Journal of Clinical Epidemiology·H W HenseU Keil
Jan 1, 1993·Journal of Cardiovascular Pharmacology·P WeidmannL Böhlen
Feb 11, 1995·Lancet·G K GoodeA M Heagerty
Jan 15, 1995·Annals of Internal Medicine·B L KasiskeT A Louis
Jan 1, 1994·Epidemiology·D StricklandR H Grimm
May 22, 1996·JAMA : the Journal of the American Medical Association·R H GrimmJ Stamler
Jun 1, 1996·Clinical and Experimental Pharmacology & Physiology·L G HowesG C Rennie
Sep 30, 1996·The American Journal of Medicine·M R WeirW B Applegate
Jun 17, 1998·JAMA : the Journal of the American Medical Association·M Moser
Sep 24, 1998·Journal of Hypertension·O H KlungelA Bakker
Dec 17, 1998·Clinical Science·S B DimmittL J Beilin
Mar 25, 1999·Archives of Internal Medicine·M R LakshmanE D Freis
Apr 28, 1999·Journal of Cardiovascular Pharmacology·R FogariP Lusardi
Nov 7, 1999·Pharmacy World & Science : PWS·O H KlungelA Bakker
Citations
Jul 17, 2008·Vascular Health and Risk Management·Panagiotis C Stafylas, Pantelis A Sarafidis
Jun 5, 2012·Vascular Health and Risk Management·Gastone Leonetti, Colin G Egan
Nov 18, 2011·American Journal of Hypertension·Steven M SmithJohn G Gums
Apr 12, 2005·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·John A PapadakisEmmanuel S Ganotakis
Feb 7, 2003·Journal of Human Hypertension·M J Tyson, P McElduff
Aug 11, 2005·Canadian Journal of Physiology and Pharmacology·Márcia M S BernikEder C R Quintão